Iovance Biotherapeutics, Inc. IOVA Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s short-term investments?
- Iovance Biotherapeutics, Inc. (IOVA) reported short-term investments of $116.94M in Q1 2026.
- How has Iovance Biotherapeutics, Inc.'s short-term investments changed year-over-year?
- Iovance Biotherapeutics, Inc.'s short-term investments decreased by 37.8% year-over-year, from $188.05M to $116.94M.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s short-term investments?
- Over 5 years (2020 to 2025), Iovance Biotherapeutics, Inc.'s short-term investments has grown at a -24.9% compound annual growth rate (CAGR), from $562.11M to $133.9M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.